Latest Articles
Endometrial Cancer: Why The Patient’s Voice Needs To Be Part Of The Treatment Plan - SurvivorNet
Endometrial Cancer: Why The Patient’s Voice Needs To Be Part Of The Treatment Plan SurvivorNet
Published: May 21, 2026, 8:02 p.m.
New treatment offers hope for endometrial cancer patients - New York Post
New treatment offers hope for endometrial cancer patients New York Post
Published: May 20, 2026, 6:34 p.m.
A First-of-Its-Kind Surgery, and the Endometriosis Patient Whose Ovary It Revived - Endometriosis Foundation of America
A First-of-Its-Kind Surgery, and the Endometriosis Patient Whose Ovary It Revived Endometriosis Foundation of America
Published: May 20, 2026, 4:29 p.m.
New drug approach offers hope for patients with recurrent aggressive cancers - Fox News
New drug approach offers hope for patients with recurrent aggressive cancers Fox News
Published: May 20, 2026, 11 a.m.
Cyclana Bio Recruits First Patients in UK Endometriosis Study - Femtech Insider
Cyclana Bio Recruits First Patients in UK Endometriosis Study Femtech Insider
Published: May 20, 2026, 10:54 a.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times
Published: May 19, 2026, 3:15 p.m.
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis - News-Medical
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis News-Medical
Published: May 19, 2026, 12:42 p.m.
Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - BioSpace
Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis BioSpace
Published: May 19, 2026, 11:15 a.m.
FinancialContent - Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - FinancialContent
FinancialContent - Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis FinancialContent
Published: May 19, 2026, 9:06 a.m.
Merck's drug helps uterine cancer patients live longer in late-stage trial - Reuters
Merck's drug helps uterine cancer patients live longer in late-stage trial Reuters
Published: May 18, 2026, 2 p.m.
Link copied to clipboard!